Position in ALVO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,730,297
-$1,253,238 QoQ
Shares Held
504,460
-13.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. ALVO ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,650,753 | $431,555,511 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,872,811 | $116,649,065 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
186,794 | $110,765,104 | |
| 4 | VTRS |
Viatris Inc
|
3,838,534 | $51,858,592 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
380,589 | $50,138,793 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
709,808 | $16,985,705 | |
| 7 | ALKS |
Alkermes plc.
|
380,722 | $13,462,329 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,411,199 | $13,434,613 |
All Filings in ALVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,730,297 | 504,460 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,983,535 | 581,586 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,315,048 | 526,868 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,998,607 | 657,742 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,438,514 | 562,411 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,622,980 | 576,189 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,421,179 | 539,595 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $6,613,398 | 543,865 | Shares | Defined | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||